DPA-Dx (Defined Partial Allergen Diagnostics) — DPA-Dx leverages purified/recombinant allergen molecules to pinpoint the exact proteins driving disease (e.g., major vs cross-reactive PR-10/LTP/tropomyosin/parvalbumin components), improving risk prediction and therapy choices. We provide DPA-Dx-enabled immunoblot panels and compatible automation (reader + software), so labs can move beyond extract-only testing and report component-level results with confidence, fully supported by our expanded supplier ecosystem.